The Leicester Diabetes Centre (LDC) launch Injectable Therapies Programme at Diabetes Professional Care (DPC) 2021

A new programme available for healthcare organisations to support people living with type 2 diabetes on Insulin or GLP-1 therapy will be launched at the DPC event on the 10th and 11th November at Olympia, London.

The Injectable Therapies Programme has been designed for people living with type 2 diabetes to have a better understanding of glycaemic control and increase knowledge and confidence to manage their diabetes.

The Injectable Therapies programme consists of four patient group sessions: one core session and three topic specific sessions.

For those who wish to offer the Injectable Therapies programme to their patients, this will mean:

Attending facilitator training – two-days for most, reduced to one-day if you/your staff are already trained in another LDC patient programme
Access to the Injectable Therapies digital portal that contains all the resources required to deliver the Injectable Therapies group sessions, either virtually or in-person.

Next steps:

If you are interested in offering the Injectable Therapies programme to your patients, please complete the form below for a bespoke quote and guidance for the next steps.

Name

First Name

Last Name

Email

Subject

Message

Recommendations to consider:

All patients would benefit from attending a diabetes structured education programme (such as DESMOND) before joining Injectable Therapies.

Groups should be delivered by two trained facilitators; at least one should be a registered Healthcare Professional.